Abstract
Brassica vegetables are attracting a great deal of attention as healthy foods because of the fact that they contain substantial amounts of secondary metabolite glucosinolates that are converted into isothiocyanates, such as sulforaphane [(−)1-isothiocyanato-4R-(methylsulfinyl)-butane] (R-SFN), through the actions of chopping or chewing the vegetables. Several studies have analyzed the biological and molecular mechanisms of the anti-cancer activity of synthetic R,S-sulforaphane, which is thought to be a result of its antioxidant properties and its ability to inhibit histone deacetylase enzymes (HDAC). Few studies have addressed the possible antioxidant effects of R-SFN, which could protect cells from the free radical damage that strongly contribute to aging. Moreover, little is known about the effect of R-SFN on stem cells whose longevity is implicated in human aging. We evaluated the effects of R-SFN on the biology on human mesenchymal stem cells (MSCs), which, in addition to their ability to differentiate into mesenchymal tissues, support hematopoiesis, and contribute to the homeostatic maintenance of many organs and tissues. Our investigation found evidence that low doses of R-SFN promote MSCs proliferation and protect them from apoptosis and senescence, while higher doses have a cytotoxic effect, leading to the induction of cell cycle arrest, programmed cell death and senescence. The beneficial effects of R-SFN may be ascribed to its antioxidant properties, which were observed when MSC cultures were incubated with low doses of R-SFN. Its cytotoxic effects, which were observed after treating MSCs with high doses of R-SFN, could be attributed to its HDAC inhibitory activity. In summary, we found that R-SFN, like many other dietary supplements, exhibits a hormetic behavior; it is able to induce biologically opposite effects at different doses.
Similar content being viewed by others
References
Abdull Razis AF, Bagatta M, De Nicola GR et al (2010a) Up-regulation of cytochrome P450 and phase II enzyme systems in rat precision-cut rat lung slices by the intact glucosinolates, glucoraphanin and glucoerucin. Lung Cancer 71(3):298–305. doi:10.1016/j.lungcan.2010.06.015
Abdull Razis AF, Iori R, Ioannides C (2010b) The natural chemopreventive phytochemical R-sulforaphane is a far more potent inducer of the carcinogen-detoxifying enzyme systems in rat liver and lung than the S-isomer. Int J Cancer. doi:10.1002/ijc.25620
Ahn YH, Hwang Y, Liu H et al (2010) Electrophilic tuning of the chemoprotective natural product sulforaphane. Proc Natl Acad Sci U S A 107(21):9590–9595. doi:10.1073/pnas.1004104107
Alexanian AR, Kurpad SN (2005) Quiescent neural cells regain multipotent stem cell characteristics influenced by adult neural stem cells in co-culture. Exp Neurol 191(1):193–197. doi:10.1016/j.expneurol.2004.10.006
Beausejour C (2007) Bone marrow-derived cells: the influence of aging and cellular senescence. Handb Exp Pharmacol 180:67–88. doi:10.1007/978-3-540-68976-8_4
Beyer Nardi N, da Silva ML (2006) Mesenchymal stem cells: isolation, in vitro expansion and characterization. Handb Exp Pharmacol 174:249–282
Bianco P, Riminucci M, Gronthos S, Gehron Robey P (2001) Bone marrow stromal stem cells: nature, biology and potential applications. Stem Cells 19:180–192
Campisi J, d’Adda di Fagagna F (2007) Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8(9):729–740
Choi S, Singh SV (2005) Bax and Bak are required for apoptosis induction by sulforaphane, a cruciferous vegetable-derived cancer chemopreventive agent. Cancer Res 65(5):2035–2043. doi:10.1158/0008-5472.CAN-04-3616
Conaway CC, Wang CX, Pittman B, Yang YM, Schwartz JE, Tian D, McIntee EJ, Hecht SS, Chung FL (2005) Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice. Cancer Res 65(18):8548–8557. doi:10.1158/0008-5472.CAN-05-0237
Cornblatt BS, Ye L, Dinkova-Kostova AT, Erb M, Fahey JW, Singh NK, Chen MS, Stierer T, Garrett-Mayer E, Argani P, Davidson NE, Talalay P, Kensler TW, Visvanathan K (2007) Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis 28(7):1485–1490. doi:10.1093/carcin/bgm049
Di Bernardo G, Squillaro T, Dell’Aversana C, Miceli M, Cipollaro M, Cascino A, Altucci L, Galderisi U (2009) Histone deacetylase inhibitors promote apoptosis and senescence in human mesenchymal stem cells. Stem Cells Dev 18(4):573–581. doi:10.1089/scd.2008.0172
Di Bernardo G, Alessio N, Dell’Aversana C et al (2010) Impact of histone deacetylase inhibitors SAHA and MS-275 on DNA repair pathways in human mesenchymal stem cells. J Cell Physiol 225(2):537–544. doi:10.1002/jcp.22236
Dinkova-Kostova AT, Jenkins SN, Fahey JW, Ye L, Wehage SL, Liby KT, Stephenson KK, Wade KL, Talalay P (2006) Protection against UV-light-induced skin carcinogenesis in SKH-1 high-risk mice by sulforaphane-containing broccoli sprout extracts. Cancer Lett 240(2):243–252. doi:10.1016/j.canlet.2005.09.012
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, and Horwitz E. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315–7.
Fimognari C, Nusse M, Cesari R, Iori R, Cantelli-Forti G, Hrelia P (2002) Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane. Carcinogenesis 23(4):581–586
Fimognari C, Nusse M, Berti F, Iori R, Cantelli-Forti G, Hrelia P (2003) Sulforaphane modulates cell cycle and apoptosis in transformed and non-transformed human T lymphocytes. Ann NY Acad Sci 1010:393–398
Foijer F, te Riele H (2006) Check, double check: the G2 barrier to cancer. Cell Cycle 5(8):831–836
Galderisi U, Di Bernardo G, Cipollaro M, Jori FP, Piegari E, Cascino A, Peluso G and Melone MAB (1999). Induction of apoptosis and differentiation in neuroblastoma and astrocytoma cells by the overexpression of Bin1, a novel Myc interacting protein. J Cell Biochem 74, 313–22
Galderisi U, Cipollaro M, Giordano A (2006) The retinoblastoma gene is involved in multiple aspects of stem cell biology. Oncogene 25(38):5250–5256
Gingras D, Gendron M, Boivin D, Moghrabi A, Theoret Y, Beliveau R (2004) Induction of medulloblastoma cell apoptosis by sulforaphane, a dietary anticarcinogen from Brassica vegetables. Cancer Lett 203(1):35–43
Haack M, Lowinger M, Lippmann D et al (2010) Breakdown products of neoglucobrassicin inhibit activation of Nrf2 target genes mediated by myrosinase-derived glucoraphanin hydrolysis products. Biol Chem 391(11):1281–1293. doi:10.1515/BC.2010.134
Haferkamp S, Scurr LL, Becker TM, Frausto M, Kefford RF, Rizos H (2009) Oncogene-induced senescence does not require the p16(INK4a) or p14ARF melanoma tumor suppressors. J Invest Dermatol 129(8):1983–1991. doi:10.1038/jid.2009.5
Hanlon N, Coldham N, Gielbert A, Sauer MJ, Ioannides C (2009) Repeated intake of broccoli does not lead to higher plasma levels of sulforaphane in human volunteers. Cancer Lett 284(1):15–20. doi:10.1016/j.canlet.2009.04.004
Ho E, Clarke JD, Dashwood RH (2009) Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention. J Nutr 139(12):2393–2396. doi:10.3945/jn.109.113332
Karmakar S, Weinberg MS, Banik NL, Patel SJ, Ray SK (2006) Activation of multiple molecular mechanisms for apoptosis in human malignant glioblastoma T98G and U87MG cells treated with sulforaphane. Neuroscience 141(3):1265–1280. doi:10.1016/j.neuroscience.2006.04.075
Keum YS, Jeong WS, Kong AN (2004) Chemoprevention by isothiocyanates and their underlying molecular signaling mechanisms. Mutat Res 555(1–2):191–202. doi:10.1016/j.mrfmmm.2004.05.024
Kim KS, Kang KW, Seu YB, Baek SH, Kim JR (2009) Interferon-gamma induces cellular senescence through p53-dependent DNA damage signaling in human endothelial cells. Mech Ageing Dev 130(3):179–188. doi:10.1016/j.mad.2008.11.004
Klimova TA, Bell EL, Shroff EH, Weinberg FD, Snyder CM, Dimri GP, Schumacker PT, Budinger GR, Chandel NS (2009) Hyperoxia-induced premature senescence requires p53 and pRb, but not mitochondrial matrix ROS. FASEB J 23(3):783–794. doi:10.1096/fj.08-114256
Maison C, Almouzni G (2004) HP1 and the dynamics of heterochromatin maintenance. Nat Rev Mol Cell Biol 5(4):296–304. doi:10.1038/nrm1355nrm1355
Masui S, Nakatake Y, Toyooka Y, Shimosato D, Yagi R, Takahashi K, Okochi H, Okuda A, Matoba R, Sharov AA, Ko MS, Niwa H (2007) Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol 9(6):625–635. doi:10.1038/ncb1589
Matoba R, Niwa H, Masui S, Ohtsuka S, Carter MG, Sharov AA, Ko MS (2006) Dissecting Oct3/4-regulated gene networks in embryonic stem cells by expression profiling. PLoS ONE 1:e26. doi:10.1371/journal.pone.0000026
Mi L, Wang X, Govind S, Hood BL, Veenstra TD, Conrads TP, Saha DT, Goldman R, Chung FL (2007) The role of protein binding in induction of apoptosis by phenethyl isothiocyanate and sulforaphane in human non-small lung cancer cells. Cancer Res 67(13):6409–6416. doi:10.1158/0008-5472.CAN-07-0340
Mi L, Xiao Z, Hood BL, Dakshanamurthy S, Wang X, Govind S, Conrads TP, Veenstra TD, Chung FL (2008) Covalent binding to tubulin by isothiocyanates. A mechanism of cell growth arrest and apoptosis. J Biol Chem 283(32):22136–22146. doi:10.1074/jbc.M802330200
Mikkers H, Frisen J (2005) Deconstructing stemness. EMBO J 24(15):2715–2719
Minucci S, Pelicci PG (2006) Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer 6(1):38–51
Muller-Sieburg CE, Deryugina E (1995) The stromal cells’ guide to the stem cell universe. Stem Cells 13(5):477–486
Myzak MC, Dashwood RH (2006) Histone deacetylases as targets for dietary cancer preventive agents: lessons learned with butyrate, diallyl disulfide, and sulforaphane. Curr Drug Targets 7(4):443–452
Myzak MC, Dashwood WM, Orner GA, Ho E, Dashwood RH (2006a) Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice. FASEB J 20(3):506–508. doi:10.1096/fj.05-4785fje
Myzak MC, Ho E, Dashwood RH (2006b) Dietary agents as histone deacetylase inhibitors. Mol Carcinog 45(6):443–446. doi:10.1002/mc.20224
Oberdoerffer P, Sinclair DA (2007) The role of nuclear architecture in genomic instability and ageing. Nat Rev Mol Cell Biol 8(9):692–702
Pelicci PG (2004) Do tumor-suppressive mechanisms contribute to organism aging by inducing stem cell senescence? J Clin Invest 113(1):4–7. doi:10.1172/JCI20750
Pessina A, Thomas RM, Palmieri S, Luisi PL (1990) An improved method for the purification of myrosinase and its physicochemical characterization. Arch Biochem Biophys 280(2):383–389
Pledgie-Tracy A, Sobolewski MD, Davidson NE (2007) Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines. Mol Cancer Ther 6(3):1013–1021. doi:10.1158/1535-7163.MCT-06-0494
Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276(5309):71–74
Ramalho-Santos M, Yoon S, Matsuzaki Y, Mulligan RC, Melton DA (2002) "Stemness": transcriptional profiling of embryonic and adult stem cells. Science 298(5593):597–600. doi:10.1126/science.10725301072530
Sethe S, Scutt A, Stolzing A (2006) Aging of mesenchymal stem cells. Ageing Res Rev 5(1):91–116
Sharpless NE, DePinho RA (2007) How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol 8(9):703–713
Sheng JG, Mrak RE, Griffin WS (1998) Enlarged and phagocytic, but not primed, interleukin-1 alpha-immunoreactive microglia increase with age in normal human brain. Acta Neuropathol 95(3):229–234
Son TG, Camandola S, Mattson MP (2008) Hormetic dietary phytochemicals. Neuromolecular Med 10(4):236–246. doi:10.1007/s12017-008-8037-y
Spotswood HT, Turner BM (2002) An increasingly complex code. J Clin Invest 110(5):577–582. doi:10.1172/JCI16547
Squillaro T, Alessio N, Cipollaro M, Renieri A, Giordano A, Galderisi U (2010) Partial silencing of methyl cytosine protein binding 2 (MECP2) in mesenchymal stem cells induces senescence with an increase in damaged DNA. FASEB J 24(5):1593–1603. doi:10.1096/fj.09-143057
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676
Talalay P, Fahey JW, Healy ZR, Wehage SL, Benedict AL, Min C, Dinkova-Kostova AT (2007) Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation. Proc Natl Acad Sci USA 104(44):17500–17505. doi:10.1073/pnas.0708710104
Taylor WR, Stark GR (2001) Regulation of the G2/M transition by p53. Oncogene 20(15):1803–1815. doi:10.1038/sj.onc.1204252
Valgimigli L, Iori R (2009) Antioxidant and pro-oxidant capacities of ITCs. Environ Mol Mutagen 50(3):222–237. doi:10.1002/em.20468
Yu AL, Fuchshofer R, Kook D, Kampik A, Bloemendal H, Welge-Lussen U (2009) Subtoxic oxidative stress induces senescence in retinal pigment epithelial cells via TGF-beta release. Investig Ophthalmol Vis Sci 50(2):926–935. doi:10.1167/iovs.07-1003
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Zanichelli, F., Capasso, S., Cipollaro, M. et al. Dose-dependent effects of R-sulforaphane isothiocyanate on the biology of human mesenchymal stem cells, at dietary amounts, it promotes cell proliferation and reduces senescence and apoptosis, while at anti-cancer drug doses, it has a cytotoxic effect. AGE 34, 281–293 (2012). https://doi.org/10.1007/s11357-011-9231-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11357-011-9231-7